Paradigm Biopharmaceuticals Ltd Requests Trading Halt
Key points
- Paradigm Biopharmaceuticals Ltd requests trading halt
- Pending announcement regarding a capital raising
- Trading halt to continue until earlier of announcement or market open on 27 April 2026
Full summary
Paradigm Biopharmaceuticals Ltd (ASX: PAR) has requested a trading halt for its securities, effective immediately. The company is seeking the trading halt pending an announcement in relation to a capital raising. The trading halt will continue until the earlier of PAR making an announcement regarding the capital raising or until the commencement of trading on Monday, 27 April 2026. PAR is not aware of any reason why the trading halt should not be granted or of any other information necessary to inform the market about the trading halt.
Summary generated by a large language model. Please interpret with care.